News & Analysis on Clinical Trial Services & Contract Research And Development
Avista Capital Partners has signed an agreement to acquire United BioSource (UBC), adding another pharmaceutical service provider to the firm’s list of current and historical investments.
Clinerion has expanded its patient recruitment system (PRS) platform to provide its clients, pharma companies, and contract research organizations (CROs) greater access to potential clinical trial participants.
Icon plc has launched a new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments as the industry continues to struggle with clinical trial recruitment.
Recipharm says three more of its facilities are equipped and ready for US Drug Supply Chain Security Act (DSCSA) serialisation demands, the deadline for which passes today.
The US FDA has issued API manufacturer Hubei Danjiangkou Danao Pharmaceutical a warning citing failures in its quality control unit.
RiBoBio has chosen GE Healthcare to equip its oligonucleotide API facility in Guangzhou, China.